Global ETD Search

Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.

Results

Showing 1 to 20 of 20 for “"Shock and kill"”.

  1. THE LATENT RESERVOIR IN ELITE CONTROLLERS AND FACTORS THAT AFFECT THE SUPPRESSIVE CAPACITIES OF IMMUNE EFFECTOR CELLS IN HIV POSITIVE INDIVIDUALS

    Our inability to efficiently target and eliminate the latent reservoir remains the biggest barrier to a cure to HIV/AIDS. Accordingly, there exist several ongoing efforts to not only understand the reservoir in varied patient groups, but also to determine an efficient means to achieve either a …

    jhu Repository record for THE LATENT RESERVOIR IN ELITE CONTROLLERS AND FACTORS THAT AFFECT THE SUPPRESSIVE CAPACITIES OF IMMUNE EFFECTOR CELLS IN HIV POSITIVE INDIVIDUALS (opens in a new tab)

  2. The impact of heptose phosphates on HIV latency and human immune responses

    … agents (ARTs) achieves total control of viremia and prevents progression of HIV to AIDS, but they are not a cure. Shock-and-kill therapy aims to use HIV latency reversal agents to promote clearance of HIV infected CD4 T-cells that make up the HIV reservoir to achieve drug-free remission from HIV. …

    toronto-retro Repository record for The impact of heptose phosphates on HIV latency and human immune responses (opens in a new tab)

  3. INVESTIGATING HIV-1 LATENCY REVERSAL UPON COGNATE ANTIGEN RECOGNITION IN CD4+ T CELLS FROM PEOPLE ON ANTIRETROVIRAL THERAPY

    … which effectively prevents viral replication and transmission, there is no cure for Human Immunodeficiency Virus type 1 (HIV-1) infection. Treatment for most persons with HIV-1 (PWH) requires lifelong adherence to ART, as its cessation results in viral rebound within weeks. Viral rebound is …

    jhu Repository record for INVESTIGATING HIV-1 LATENCY REVERSAL UPON COGNATE ANTIGEN RECOGNITION IN CD4+ T CELLS FROM PEOPLE ON ANTIRETROVIRAL THERAPY (opens in a new tab)

  4. Cell intrinsic innate immunity protein RPRD2 restricts transcription from the HIV-1 LTR in human cell lines

    … therapy is never curative. The establishment and persistence of latency are complex and still incompletely characterised. Host factors that repress retroviral transcription are thought to be involved in this phenomenon. RPRD2 was identified as an antiviral protein that restricts HIV …

    edinburgh Repository record for Cell intrinsic innate immunity protein RPRD2 restricts transcription from the HIV-1 LTR in human cell lines (opens in a new tab)

  5. Mechanistic approaches for reactivation and elimination of latent HIV-1

    … expression maintains this barrier to a cure. Shock-and-kill, a prominent strategy for HIV-1 eradication, requires the reactivation of latent HIV-1 gene expression. Global T cell activation is a well-characterized means of inducing HIV-1 transcription, but is considered too toxic for clinical …

    jhu Repository record for Mechanistic approaches for reactivation and elimination of latent HIV-1 (opens in a new tab)

  6. Development of the Molecular Biology of HIV-Seek: A Novel Approach to Characterizing Latently Infected CD4+ T Cells

    … (ART) is effective at managing HIV infection and extending the lives of people living with HIV (PLWH), it is limited by the inability to target the HIV viral reservoir, specifically in latently infected CD4+ T cells. Strategies for targeting the viral reservoir, including “shock and kill” and …

    hawaii Repository record for Development of the Molecular Biology of HIV-Seek: A Novel Approach to Characterizing Latently Infected CD4+ T Cells (opens in a new tab)

  7. Development of Microfluidics for Use in a Novel Way to Characterize Latently HIV-Infected Cells

    … considered for eradicating latent HIV such as “shock and kill” and “block and lock”but are still in development and have shown poor results in clinical trials thus far. Laboratory techniques such as STIP-Seq and HIV-Flow have been developed to quantify and characterize the HIV reservoir but do …

    hawaii Repository record for Development of Microfluidics for Use in a Novel Way to Characterize Latently HIV-Infected Cells (opens in a new tab)

  8. Role of the Tigit Immune Checkpoint Pathway in the Eradication of HIV Infection

    … contributes substantially to global morbidity and mortality, with no immediate promise of an effective vaccine or cure. One major obstacle to vaccine development and therapy is to understand why HIV replication persists in a person despite the presence of viral specific immune responses. The …

    hawaii Repository record for Role of the Tigit Immune Checkpoint Pathway in the Eradication of HIV Infection (opens in a new tab)

  9. Generation of an HIV-inducible intron expression cassette as a novel AAV-based therapy against latent HIV infection

    … cells persist until cART lose effectiveness and symptoms arise again. A therapeutic approach able to eradicate chronically infected cells would then be desirable to cure – rather than restrain – HIV infection.<br/><br/>The focus of this work was therefore to evaluate whether a novel …

    kings Repository record for Generation of an HIV-inducible intron expression cassette as a novel AAV-based therapy against latent HIV infection (opens in a new tab) Download PDF for Generation of an HIV-inducible intron expression cassette as a novel AAV-based therapy against latent HIV infection (opens in a new tab)

  10. DESIGN AND DEVELOPMENT OF BISPECIFIC ANTIBODIES FOR HIV-1 RESERVOIR ELIMINATION

    … human immunodeficiency virus type 1 (HIV-1), and despite advances in HIV-1 prevention, there are still 1.5 million new cases annually. Although antiretroviral therapy (ART) regimens suppress viral replication and prevent immunodeficiency, ART is not curative and cessation of treatment results …

    jhu Repository record for DESIGN AND DEVELOPMENT OF BISPECIFIC ANTIBODIES FOR HIV-1 RESERVOIR ELIMINATION (opens in a new tab)

  11. T Cell Effector Responses in HIV-1 Cure Strategies

    … over 35 million individuals around the world, and yet despite present treatments, there remains a need for a cure. A current cure tactic widely researched is the “shock and kill” strategy, where cART-treated HIV-positive individuals would be given latency reactivating agents (LRAs) to induce …

    jhu Repository record for T Cell Effector Responses in HIV-1 Cure Strategies (opens in a new tab)

  12. Characterization and exploitation of host factors to modulate HIV-1 latency

    … viral replication. However, ART is not a cure and must be administered life-long with discontinuation resulting in viral rebound. The persistence of HIV-1 is the result of a fraction of provirus establishing latency early upon infection of T cells. This population of transcriptionally silent …

    ubc Repository record for Characterization and exploitation of host factors to modulate HIV-1 latency (opens in a new tab) Download PDF for Characterization and exploitation of host factors to modulate HIV-1 latency (opens in a new tab)

  13. Small molecules effective for disruption of HIV-1 latency

    … of the disease. This thesis focuses on the shock phase of a proposed cure strategy known as “shock and kill,” which aims to induce latent HIV-1 reservoirs that could then be purged via a boosted immune response, specific targeting of infected cells, or by viral-induced apoptosis. …

    ubc Repository record for Small molecules effective for disruption of HIV-1 latency (opens in a new tab) Download PDF for Small molecules effective for disruption of HIV-1 latency (opens in a new tab)

  14. Strategies to Facilitate the Eradication of the HIV-1 Reservoir

    … Virus type 1 (HIV-1) infection globally and more than 70 million deaths can be attributed to the pathogen so far. HIV-1 primarily infects CD4 T cells leading to their widespread destruction that eventually manifests as Acquired Immunodeficiency Syndrome (AIDS), characterized by …

    toronto-retro Repository record for Strategies to Facilitate the Eradication of the HIV-1 Reservoir (opens in a new tab)

  15. A CRISPR Screen of HIV Dependency Factors to Identify Host Proteins Necessary for Activation of Latent HIV Proviruses

    … virus (HIV) integrates into host DNA and therefore persists as a long-lived pathogen in people living with HIV (PLHIV). One of the greatest challenges to achieving a cure for human immunodeficiency virus (HIV) is the presence of latently infected long-lived immune cells that endure …

    washington Repository record for A CRISPR Screen of HIV Dependency Factors to Identify Host Proteins Necessary for Activation of Latent HIV Proviruses (opens in a new tab)

  16. A CRISPR-screening approach to increase HIV latency reversal to improve an HIV cure strategy

    … is currently no way to eradicate the long-lived and stable HIV reservoir that evades the immune system but retains the ability to reactivate and spread virus. Understanding mechanisms that govern HIV latency within these reservoirs, such as host and viral factors that influence transcription …

    washington Repository record for A CRISPR-screening approach to increase HIV latency reversal to improve an HIV cure strategy (opens in a new tab)

  17. Pharmacologic Stratagies Toward Curing HIV-1 Infection: Identification and Evaluation of Small-Molecule HIV-1 Latency Reversing Agents

    … pharmacologic induction of HIV-1 transcription and subsequent killing of infected cells by cytolytic T lymphocytes (CTLs) or viral cytopathic effects. Initial strategies to reactivate latent HIV-1 through nonspecific global T cell activation proved to have unacceptable toxicity, precluding its …

    jhu Repository record for Pharmacologic Stratagies Toward Curing HIV-1 Infection: Identification and Evaluation of Small-Molecule HIV-1 Latency Reversing Agents (opens in a new tab)

  18. On the Origin of AIDS: CARD8’s Role in Pathogenesis and Cure

    … health burden with 1.7 million new acquisitions and 770,000 deaths in 2018 alone. While these numbers are declining due to antiretroviral therapy, only a handful of individuals have achieved complete remission from HIV. With the advent of antiretroviral therapy, HIV has turned a death sentence …

    wustl Repository record for On the Origin of AIDS: CARD8’s Role in Pathogenesis and Cure (opens in a new tab)

  19. Opioid use disorder suppresses HIV-1 latent reactivation in people with HIV and a strategy for permanent repression of HIV-1 expression

    … opioid use affects the host immune system and increases an individual’s susceptibility to HIV infection. However, it is unclear how opioid use changes the course of HIV pathogenesis. Particularly, there is a gap in understanding how opioids impact HIV latency. Latency results in a reservoir …

    bu Repository record for Opioid use disorder suppresses HIV-1 latent reactivation in people with HIV and a strategy for permanent repression of HIV-1 expression (opens in a new tab)